Literature DB >> 10995523

How aggressively should blood pressure be treated in renal transplant recipients?

D K Klassen1.   

Abstract

Renal transplantation is the treatment of choice for many patients with endstage renal disease. Patient survival is improved compared with dialysis for all patient ages and racial groups. Renal allograft survival is closely connected with recipient blood pressure. Blood pressure treatment goals that improve patient outcome have been defined for patients with nontransplant renal disease but not for patients with renal transplants. Extrapolating from data from nonrenal transplant patients suggests that aggressive treatment of hypertension in renal transplant patients may improve allograft and patient survival.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995523     DOI: 10.1007/s11906-000-0030-2

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  19 in total

1.  ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy.

Authors:  C E Stigant; J Cohen; M Vivera; J S Zaltzman
Journal:  Am J Kidney Dis       Date:  2000-01       Impact factor: 8.860

2.  Antihypertensive medication and renal allograft failure: a North American Pediatric Renal Transplant Cooperative Study report.

Authors:  J M Sorof; E K Sullivan; A Tejani; R J Portman
Journal:  J Am Soc Nephrol       Date:  1999-06       Impact factor: 10.121

3.  Arterial hypertension and renal allograft survival.

Authors:  K C Mange; B Cizman; M Joffe; H I Feldman
Journal:  JAMA       Date:  2000-02-02       Impact factor: 56.272

4.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

5.  Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction?

Authors:  U Frei; R Schindler; D Wieters; U Grouven; R Brunkhorst; K M Koch
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

6.  Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients.

Authors:  D del Castillo; J M Campistol; L Guirado; L Capdevilla; J G Martínez; P Pereira; J Bravo; R Pérez
Journal:  Kidney Int Suppl       Date:  1998-12       Impact factor: 10.545

7.  Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

Authors:  J C Peterson; S Adler; J M Burkart; T Greene; L A Hebert; L G Hunsicker; A J King; S Klahr; S G Massry; J L Seifter
Journal:  Ann Intern Med       Date:  1995-11-15       Impact factor: 25.391

8.  Racial differences in renal allograft survival: the role of systemic hypertension.

Authors:  F G Cosio; J J Dillon; M E Falkenhain; R J Tesi; M L Henry; E A Elkhammas; E A Davies; G L Bumgardner; R M Ferguson
Journal:  Kidney Int       Date:  1995-04       Impact factor: 10.612

9.  Blood pressure and end-stage renal disease in men.

Authors:  M J Klag; P K Whelton; B L Randall; J D Neaton; F L Brancati; C E Ford; N B Shulman; J Stamler
Journal:  N Engl J Med       Date:  1996-01-04       Impact factor: 91.245

10.  Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival.

Authors:  J S Cheigh; R H Haschemeyer; J C Wang; R R Riggio; L Tapia; K H Stenzel; A L Rubin
Journal:  Am J Hypertens       Date:  1989-05       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.